HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    
Learn more
Self Investors Wanted Today

Few spots available. Master Zacks' market-tripling Stock Picking Method in your home at our cost.
Opportunity ends Saturday, Nov. 21 >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


ABC: Amerisourcebergen Corp - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

AMERISOURCEBERGEN CORP (NYSE)
ABC 24.49 0.28 (1.16%) Vol.  4,907,262 16:00 ET

Day Low - High 24.17 - 24.70
52wk Low - High 13.75 - 24.85
Avg Volume 3,112,077
Industry MED-WHSL DRG/SN
Market Cap 7.20 B
Div - Yield 0.24 - 0.99
PE (forward) 12.86
PEG Ratio 1.05
Current Year Est. 1.88
EPS Last Year 1.70
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
#1 Strong Buy 26.51%
#2 Buy 16.63%
#3 Hold 7.53%
#4 Sell 2.01%
#5 Strong Sell -0.07%
S&P 500 8.70%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


upgraded 11/21/2009
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 09/01/2009
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
AMERISOURCEBERGEN CORP ABC PREMIUM
PERRIGO COMPANY PRGO PREMIUM
OMNICARE INC OCR PREMIUM
MCKESSON CORP MCK PREMIUM
See all MED-WHSL DRG/SN Peers

BROKERAGE RECOMMENDATIONS
Current ABR 1.94
ABR (Last Week) 1.94
# of Recs in ABR 16
Average Target Price 26.03
Industry Rank by ABR 48 out of 217
Rank in Industry 6 out of 11
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate ABC?
Buy
Sell
Find out what the Zacks Community
thinks of ABC at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR ABC
Closing Market Commentary: Market Advanced on Strong Earnings
Nov 13, 2009
Closing Market Commentary: Stocks Fell on Lower Energy Usage
Nov 12, 2009
Zacks Blog: AmerisourceBergen Tops
Nov 03, 2009
Closing Market Commentary: Buffett's Deal and Higher Commodities Propelled Stocks
Nov 03, 2009
Closing Market Commentary: Bears Took Over on Discouraging Data
Oct 30, 2009
More Zacks Commentary
NEWS
Rothman Research Follow-up on DTE Energy Co., HRPT Properties Trust,Massey Energy Co., AmerisourceBergen Corporation, WeatherfordInternational Ltd. and Zimmer Holdings Inc.
Nov 20, 2009
AmerisourceBergen Closes $400 Million Offering Of Senior Notes
Nov 20, 2009
AmerisourceBergen Completes Public Offering of $400 Million 4.875% Senior Notes Due 2019
Nov 19, 2009
UBS Gives AmerisourceBergen (ABC) An Upgrade
Nov 19, 2009
AmerisourceBergen (ABC) Initiated Coverage Alert, Watch for 51.2% Technical Uptrend Continuation
Nov 19, 2009
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
09/2010
Next Year
09/2011
Average Estimate 0.42 0.53 1.89 2.06
Number of Estimates 14 13 16 13
Low Estimates 0.40 0.50 1.82 1.92
High Estimate 0.44 0.55 1.95 2.15
Year Ago EPS 0.37 0.47 1.69 1.89
EPS Growth 15.66% 10.61% 11.65% 9.26%

More Estimates

COMPANY DESCRIPTION
AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education.

Full Company Report
FINANCIALS
EPS TTM 1.7
Sales 71759.99
Net Income 503.4
Price/Earnings 14.24
Price/Book 2.65
Price/Cash Flow 12.18
Price/Sales .1


More Financials

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research